Build alongside an integrated biosciences group
SCIBEX engages strategic partners across manufacturing, distribution, research and technology — through a single, coordinated point of contact.
SCIBEX Biosciences Group does not offer any public stock, shares or securities through this website. Investor relations here refers to structured dialogue with aligned, long-horizon partners. Nothing on this page constitutes an offer or solicitation of investment.
Eight routes to working with SCIBEX
Whatever your field, there is likely a way to collaborate across the group's five divisions.
Investor Relations
Structured dialogue with aligned, long-horizon investors.
Strategic Alliances
Cross-sector alliances that strengthen the group platform.
Manufacturing Partnerships
GMP-aligned manufacturing collaboration opportunities.
Distribution Partnerships
Distributor networks across healthcare and wellness.
Export Collaboration
Cross-border trade collaboration through SCIBEX IMEX.
Research Partnerships
Joint research aligned to our innovation roadmap.
Technology Partnerships
Technology collaboration for digital and preventive health.
Healthcare Ecosystem
Partnerships across the wider healthcare ecosystem.
One relationship, five divisions
Partnering with SCIBEX means access to an integrated platform spanning pharmaceuticals, Ayurveda, functional beverages, global trade and health innovation. A single conversation can open collaboration across the whole group.
The group's India–USA structure also positions partners for cross-border opportunity, coordinated through SCIBEX IMEX.
What partners can expect
- • A single coordinated point of contact
- • Access across all five SCIBEX divisions
- • An India–USA cross-border bridge
- • Honest, transparent commercial dialogue
Discuss a partnership with SCIBEX
Tell us about your organisation and goals — our team will route your inquiry to the right division.
Contact our team